Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis
Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis
Not yet recruiting · NCT07093268 · Registry updated 2025-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Not yet recruiting | Phase 1 | 2025-07-30 | NCT07093268 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brain Trust Bio | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Flinders Medical Centre | Bedford Park | Australia | 72 |
| Sunshine Coast University Hospital | Birtinya | Australia | 34 |